Decan,
I was heartened to see some reasonably positive coverage in the Australian today, until I read the bit that said:
"It is seeking US Food and Drug Administration approval to start a planned 60-patient phase II trial of its CancerVac product."
If that reporting of fact today is accurate, then it means you are correct regarding the testing phase level CVac is approaching in the US market and I was wrong, having apparently misinterpreted what PRR meant to convey in its May announcement.
worst corporate governance on the asx, page-85
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.010(2.50%) |
Mkt cap ! $566.5M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.5¢ | 38.5¢ | $997.5K | 2.559M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 85852 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 75389 | 4 |
View Market Depth
| Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |